⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1359211 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL9127358 | 0.97 | — | — | |
| SCHEMBL25487800 | 0.82 | — | — | |
| SCHEMBL830552 | 0.78 | — | — | |
| SCHEMBL29011216 | 0.76 | — | — | |
| SCHEMBL9529554 | 0.75 | — | — | |
| SCHEMBL18140092 | 0.71 | TDP1 (0.36) | — | |
| SCHEMBL17633086 | 0.71 | HPGD (0.36) | — | |
| SCHEMBL15998905 | 0.71 | MAPT (0.69) | — | |
| SCHEMBL9127347 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106519147-B | The product and preparation method of micro Nano material, its surface hydrophilic substance covalent modification | 重庆博蓝鹰生物技术有限公司 | 2017-10-17 | — | — | CN | claimed |
| CN-106519147-A | Micro-nano material, product of covalent modification of hydrophilic substances for surface of micro-nano material, and preparation method | 重庆博蓝鹰生物技术有限公司 | 2017-03-22 | — | — | CN | claimed |
| US-8690857-B2 | Alleviate back pain with lactic acid inhibitors | ALEEVA MEDICAL INC. (US) | 2014-04-08 | — | — | US | claimed |
| US-20120022425-A1 | Alleviate back pain with lactic acid inhibitors | YEUNG JEFFREY ERIC (US) | 2012-01-26 | — | — | US | claimed |
| EP-4683579-A1 | RELIEVE BACK PAIN AND/OR REBUILDING INTERVERTERAL DISC | Yeung, Jeffrey E. (US) | 2026-01-28 | — | — | EP | disclosed |
| WO-2024158529-A1 | RELIEVE BACK PAIN AND/OR REBUILDING INTERVERTERAL DISC | YEUNG JEFFREY E (US) | 2024-08-02 | — | — | WO | disclosed |
| CN-110156820-B | Mercaptoamide boronic acid derivatives and application thereof as MBL (sodium Bromide) and/or SBL (SBL) inhibitor | 四川大学 | 2021-06-25 | — | — | CN | disclosed |
| WO-2020196140-A1 | POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIALS | 三菱瓦斯化学株式会社 | 2020-10-01 | — | — | WO | disclosed |
| WO-2020061670-A1 | LIPOSOMAL FORMULATION, PHARMACEUTICAL COMPOSITION, USE OF A LIPOSOMAL FORMULATION, METHOD FOR TREATING CANCER, AND PROCESS FOR PREPARING A LIPOSOMAL FORMULATION | UNIVERSIDADE FEDERAL DO RIO DE JANEIRO (BR) | 2020-04-02 | — | — | WO | disclosed |
| US-10561503-B2 | Method for relieving pain and regenerating intervertebral disc | ALEEVA MEDICAL INC. (US) | 2020-02-18 | — | — | US | disclosed |
| CN-106946843-B | Preparation method of 3-acyl-1, 4-oxathiolane | 北京化工大学 | 2019-12-31 | — | — | CN | disclosed |
| CN-110156820-A | A kind of Mercaptoamides boric acid analog derivative and its purposes as MBL and/or SBL inhibitor | 四川大学 | 2019-08-23 | — | — | CN | disclosed |
| WO-2003008452-A2 | BISPECIFIC MONOCLONAL ANTIBODIES TO IL-12 AND IL-18 RECEPTORS | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-01-30 | — | — | WO | disclosed |
| WO-2002092834-A2 | HIGH CAPACITY ASSAY PLATFORMS | SIGMA-ALDRICH CO. (US) | 2002-11-21 | — | — | WO | disclosed |
| EP-0728144-B1 | PEPTIDYL COMPOUNDS AND THEIR THERAPEUTIC USE AS INHIBITORS OF METALLOPROTEINASES | DARWIN DISCOVERY LTD (GB) | 2000-01-19 | — | — | EP | disclosed |
| US-5853623-A | Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases | CHIROSCIENCE LIMITED (GB) | 1998-12-29 | — | — | US | disclosed |
| EP-0728144-A1 | PEPTIDYL COMPOUNDS AND THEIR THERAPEUTIC USE AS INHIBITORS OF METALLOPROTEINASES | Chiroscience Limited (GB) | 1996-08-28 | — | — | EP | disclosed |
| WO-1995013289-A1 | PEPTIDYL COMPOUNDS AND THEIR THERAPEUTIC USE AS INHIBITORS OF METALLOPROTEINASES | CHIROSCIENCE LIMITED (GB) | 1995-05-18 | — | — | WO | disclosed |
| US-4460601-A | Dipeptides having a methionine residue and possessing a protective action for the liver | MAGGIONI FARMACEUTICI, S.P.A. (IT) | 1984-07-17 | — | — | US | disclosed |
| EP-0093915-A1 | Novel beta-lactam derivatives | GRUPPO LEPETIT S.P.A. (IT) | 1983-11-16 | — | — | EP | disclosed |